Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-11
2011-01-11
Chong, Yong S (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07868028
ABSTRACT:
Novel guanidine compounds having the formulain which R1, R2and R4are as defined, are effective as sodium channel blockers in neuronal mammalian cells and as anesthetics and/or analgesics, particularly local spinal and/or epidural anesthetics, for alleviation of neuropathic pain, for providing a neuroprotective effect, and for producing anti-convulsant effects.
REFERENCES:
patent: 5688830 (1997-11-01), Berger et al.
patent: 1177792 (2002-02-01), None
patent: 2002155060 (2002-05-01), None
patent: 1326608 (1987-07-01), None
Popov et al., Khimlya Geterotslklichesklkh Soedinenii (1996), (10), 1352-1357, CAPLUS Accession No. 126:47152.
Anisimova et al., Khimiko-Farmatsevticheskii Zhurnal (1987), 21(3), 313-319, CAPLUS Accession No. 1988:5879.
Anisimova et al., Khimiya-Gaterotsiklicheskikh Soedinenii (1986), (7), 918-925, CAPLUS Accession No. 1987:477696.
Drasner Kenneth
Weber Kevin T.
Chong Yong S
Davis , Wright, Tremaine, LLP
Drasner Fred
Rondeau, Jr. George C.
LandOfFree
Guanidine compounds as anesthetics and for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine compounds as anesthetics and for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine compounds as anesthetics and for treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2690687